Lynch Syndrome: New Cancer Risk Biomarker Found
A significant leap forward in personalized cancer prevention has been achieved by researchers at MD Anderson Cancer Center: a blood-based biomarker capable of identifying individuals with Lynch Syndrome (LS) at heightened risk of developing cancer, even *before* symptoms appear. This isn’t simply a diagnostic advance; it represents a paradigm shift towards proactive, immune-informed risk stratification … Read more